Literature DB >> 1449626

[Morbidity reduction in preterm newborns fed with milk of their own mothers].

J Contreras-Lemus1, S Flores-Huerta, I Cisneros-Silva, H Orozco-Vigueras, J Hernández-Gutiérrez, J Fernández-Morales, F Chávez-Hernández.   

Abstract

In order to study the effect of feeding on the morbidity, 118 premature newborn, were followed on successive basis; 59 fed with infant term formula (F) and 59 fed with own mother's milk (LH). The patients were classified in 3 groups according to birth weight: I, < 999 g (n = 4/4); II, 1000-1499 g (n = 37/37) and III, 1500-1999 g (n = 18/18), each group F and LH having equal numbers. Growth, morbidity and clinical management were recorded. Necrotizing enterocolitis (P < 0.001), urinary tract infection (P < 0.01) and infectious diarrhea (P < 0.01) were less frequent in LH infants and as a consequence these infants needed less antimicrobial therapy (P < 0.001), nevertheless the human milk contained flora bacteria. The LH infants of group II need fewer red cell transfusions (P < 0.001) and each group was similar and only the babies < 999 g had increments of approximately 15 g/kg/day. This study highlights the importance of feeding the premature infant with own mother's milk; however, the infant growth increments were less than the expected suggesting that human milk must be fortified with proteins and minerals, considering the mothers as a true human milk bank.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449626

Source DB:  PubMed          Journal:  Bol Med Hosp Infant Mex        ISSN: 0539-6115


  2 in total

Review 1.  Effects of nutrients in human milk on the recipient premature infant.

Authors:  R J Schanler; S A Atkinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-07       Impact factor: 2.673

Review 2.  Does human milk reduce infection rates in preterm infants? A systematic review.

Authors:  A de Silva; P W Jones; S A Spencer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-11       Impact factor: 5.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.